durvalumab,sorafenib,tremelimumab
astrazeneca,pfizer
['himalaya', 'hcc']
 himalaya: outcomes by occurrence of imaes stride/d in #hcc #asco23 imaes with stride/d manageable improvement in os with stride (not d) in pts with imaes: 23 vs 14 mo mechanisms? may be helpful information for some pts with imaes 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision oncology